Mr. David Ebersman is a Co-Founder and serves as the Chief Executive Officer and a Board Member at Lyra Health. He is a Board member at Castlight Health. He was the Chief Financial Officer of Facebook. Prior to joining Facebook, he held a number of positions at Genentech, a leading public biotechnology company, until its acquisition by Hoffmann-La Roche in March 2009. At Genentech, he was appointed executive vice president in January 2006 and chief financial officer in March 2005. Previously, he served as senior vice president, finance from January 2005 through March 2005 and senior vice president, product operations from May 2001 through January 2005. He joined Genentech in February 1994 as a business development analyst and subsequently served as manager, business development from February 1995 to February 1996, director, business development from February 1996 to March 1998, senior director, product development from March 1998 to February 1999 and vice president, product development from February 1999 to May 2001. Prior to joining Genentech, He held the position of research analyst at Oppenheimer & Company. Mr. Ebersman was selected as a Fellow in the Henry Crown Fellowship Program. Mr. Ebersman received a B.A. in economics and international relations from Brown University. He serves as the Board Member at Castlight Health.